tiprankstipranks
Tenax Therapeutics (TENX)
NASDAQ:TENX
US Market
TENX
Tenax Therapeutics
RESEARCH TOOLSreports

Tenax Therapeutics (TENX) Financial Statements

Compare
639 Followers

Tenax Therapeutics Financial Overview

Tenax Therapeutics's market cap is currently $257.45M. The company's EPS TTM is $-0.38; its P/E ratio is ―; Tenax Therapeutics is scheduled to report earnings on March 10, 2026, and the estimated EPS forecast is $-0.40. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Mar 23Mar 22
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income$ -56.38M$ -19.49M$ -8.23M$ -11.05M$ -32.73M
EBITDA$ -56.38M$ -17.58M$ -7.68M$ -10.93M$ -32.36M
Net Income$ -52.60M$ -17.60M$ -7.71M$ -11.05M$ -32.47M
Balance Sheet
Cash & Short-Term Investments$ 97.56M$ 94.85M$ 9.79M$ 2.12M$ 5.58M
Total Assets$ 104.23M$ 96.69M$ 11.68M$ 3.40M$ 5.99M
Total Debt$ 0.00$ 0.00$ 500.90K$ 807.89K$ 290.78K
Net Debt$ -97.56M$ -94.85M$ -9.29M$ -1.32M$ -5.29M
Total Liabilities$ 7.16M$ 4.69M$ 3.59M$ 1.91M$ 1.75M
Stockholders' Equity$ 97.07M$ 91.99M$ 8.10M$ 1.49M$ 4.24M
Cash Flow
Free Cash Flow$ -35.80M$ -14.81M$ -5.90M$ -12.02M$ -10.86M
Operating Cash Flow$ -35.80M$ -14.81M$ -5.90M$ -12.01M$ -10.86M
Investing Cash Flow$ 0.00$ 0.00$ 3.00K$ -2.32K$ 452.61K
Financing Cash Flow$ 38.51M$ 99.87M$ 13.57M$ 8.55M$ 9.74M
Currency in USD

Tenax Therapeutics Earnings and Revenue History

Income Statement >

Tenax Therapeutics Debt to Assets

Balance Sheet >

Tenax Therapeutics Cash Flow

Cash Flow >

Tenax Therapeutics Forecast EPS vs Actual EPS

Earnings >